Deloitte
Dr. Bill Fera, genAI leader for life sciences and healthcare at Deloitte Consulting, relays how governance, trust and human oversight are essential to scaling AI responsibly.
Dr. Bill Fera, principal at Deloitte, highlights the importance of human oversight in healthcare AI and shares his insights on the next big innovations in the sector.
CasePointer's workforce will join Deloitte, and the company will use the business's software in conjunction with its GovConnect assets to assist its government clients.
A report published by Deloitte says employers can help Americans live longer, gaining nearly 20 more healthy years, utilizing current innovation.
Dr. Jay Bhatt, managing director at Deloitte, warns that without high-quality algorithms technology has the potential to increase health inequities and drive mistrust.
Peter Micca, audit and assurance partner and national health tech leader at Deloitte, discusses the health tech funding and economic environment.
According to Deloitte's survey, 49% of respondents said they'd attended a virtual medical appointment as a patient in the past year, while 26% said they'd been to a virtual visit where another person was the patient.
Deloitte's Bill Fera discussed at HIMSS22 what a post-pandemic digital future could look like.
Also: Dr. Jay Bhatt becomes executive director of Deloitte Center for Health Solutions, and Owkin names two new executives.
2022 Look Ahead
Deloitte’s Road to Next report found health tech investments totaled $23.8 billion across 556 completed transactions so far this year.